Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Novartis v. Breckenridge: Obviousness-Type Double Patenting Explained
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
IP Update – Canada | New Patent Rules released: 12 Notable Changes & Tips
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)
The PTAB continues to reverse examiner 101 rejections
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)
More PTAB 101 Reversals – stems cells & inventory management & options trading
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Life Science Patenting to Iancu – “We need help too!”
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)
More Section 101 reversals from PTAB
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)
Ancora v HTC America: restriction computer operations with license limitation eligible under Section 101
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)
Still a Challenge Getting a Reversal at the PTAB on 101 Eligibility Rejections
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Kumar v. Iancu – The Dangers of an Overstuffed Preamble/Note on 37 CFR Part 4.
Webinar
On Demand
![SLWI Banner22 SLWI Banner22](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner22-305x180.jpg)
#9 – Biosimilars: Patentable Approaches and Surveillance
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)
More PTAB Reversals of Examiner 101 Rejections
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)